Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $656,835 (100.0% shares, 0.0% debt)

Holdings (32)

XENE XENON PHARMACEUTICALS INC 10.1%
Value ($000) $66,033 Shares 1,845,000 Est. Cost $26.06 Unrealized +41.8%
VRDN VIRIDIAN THERAPEUTICS INC 8.5%
Value ($000) $55,705 Shares 2,189,659 Est. Cost $17.59 Unrealized +82.3%
MERUS N V 8.3%
Value ($000) $54,280 Shares 2,950,000 Est. Cost $24.11 Unrealized
COGT COGENT BIOSCIENCES INC 7.8%
Value ($000) $51,494 Shares 4,772,421 Est. Cost $8.50 Unrealized +50.5%
BELLUS HEALTH INC NEW 7.2%
Value ($000) $47,371 Shares 6,579,359 Est. Cost $7.56 Unrealized
AMBRX BIOPHARMA INC 6.5%
Value ($000) $42,847 Shares 4,803,447 Est. Cost $8.92 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 5.8%
Value ($000) $37,917 Shares 1,731,365 Est. Cost $20.34 Unrealized 0.0%
AKERO THERAPEUTICS INC 4.6%
Value ($000) $30,225 Shares 790,000 Est. Cost $35.40 Unrealized
NUVL NUVALENT INC 4.3%
Value ($000) $28,047 Shares 1,075,000 Est. Cost $28.14 Unrealized +5.1%
IMVT IMMUNOVANT INC 3.4%
Value ($000) $22,350 Shares 1,440,999 Est. Cost $13.55 Unrealized +28.1%
VERA VERA THERAPEUTICS INC 3.3%
Value ($000) $21,914 Shares 2,824,029 Est. Cost $7.72 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 2.7%
Value ($000) $18,034 Shares 853,884 Est. Cost $22.91 Unrealized +8.6%
CLDX CELLDEX THERAPEUTICS INC NEW 2.7%
Value ($000) $17,840 Shares 495,823 Est. Cost $30.35 Unrealized +42.2%
CYMABAY THERAPEUTICS INC 2.7%
Value ($000) $17,658 Shares 2,025,000 Est. Cost $4.40 Unrealized
CABA CABALETTA BIO INC 2.3%
Value ($000) $15,175 Shares 1,835,000 Est. Cost $6.21 Unrealized +50.7%
KURA KURA ONCOLOGY INC 2.2%
Value ($000) $14,737 Shares 1,204,958 Est. Cost $14.26 Unrealized -12.5%
ARWR ARROWHEAD PHARMACEUTICALS IN 2.2%
Value ($000) $14,605 Shares 575,000 Est. Cost $36.39 Unrealized -13.6%
CELC CELCUITY INC 2.2%
Value ($000) $14,255 Shares 1,390,772 Est. Cost $20.36 Unrealized -46.2%
PROMETHEUS BIOSCIENCES INC 2.1%
Value ($000) $13,646 Shares 127,156 Est. Cost $0.11 Unrealized
ALPINE IMMUNE SCIENCES INC 1.6%
Value ($000) $10,229 Shares 1,325,000 Est. Cost $7.20 Unrealized
DAWN DAY ONE BIOPHARMACEUTICALS I 1.5%
Value ($000) $9,889 Shares 739,661 Est. Cost $10.33 Unrealized +89.2%
RNAM AVIDITY BIOSCIENCES INC 1.4%
Value ($000) $9,067 Shares 590,705 Est. Cost $14.91 Unrealized +47.6%
ENTA ENANTA PHARMACEUTICALS INC 1.3%
Value ($000) $8,786 Shares 217,253 Est. Cost $51.53 Unrealized -7.3%
ALLAKOS INC 1.3%
Value ($000) $8,455 Shares 1,900,000 Est. Cost $5.89 Unrealized
PCVX VAXCYTE INC 1.1%
Value ($000) $7,496 Shares 200,000 Est. Cost $39.66 Unrealized +6.9%
ACRS ACLARIS THERAPEUTICS INC 0.8%
Value ($000) $5,137 Shares 635,000 Est. Cost $12.97 Unrealized -2.2%
THIRD HARMONIC BIO INC 0.6%
Value ($000) $4,092 Shares 993,294 Est. Cost $18.97 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.5%
Value ($000) $3,587 Shares 5,000,000 Est. Cost $0.72 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.4%
Value ($000) $2,457 Shares 312,553 Est. Cost $24.62 Unrealized -69.7%
RZLT REZOLUTE INC 0.3%
Value ($000) $1,725 Shares 898,267 Est. Cost $3.32 Unrealized -32.3%
ABOS ACUMEN PHARMACEUTICALS INC 0.2%
Value ($000) $1,624 Shares 400,000 Est. Cost $5.74 Unrealized -8.9%
DBV TECHNOLOGIES S A 0.0%
Value ($000) $157 Shares 92,687 Est. Cost $0.00 Unrealized